Altmetric now tracks clinical impact of resea

0
Altmetric Clinical Guidelines - sample image 1

image: 

An example of how clinical guidelines appear in Altmetric.


view more 

Credit: Altmetric / Digital Science.

Digital Science is pleased to announce that its flagship product Altmetric, which gauges the online attention of research, has added a new attention source: Clinical Guidelines.

The new attention source will enable Altmetric to track the impact of research in clinical practice. Clinical Guidelines will be reflected in the distinctive Altmetric Badges – appearing as an aqua green color – as well as in Altmetric Attention Scores, and will appear in more detail in Altmetric Explorer.

Clinical Guidelines complement Altmetric’s full breadth of attention sources, including social media, news, public policy and documents, academic forums, blog sources, patents and more.

As documents that offer recommendations for clinicians and healthcare practitioners on how to manage and treat specific medical conditions or support decision-making in patient care, Clinical Guidelines are a critical source of attention to demonstrate real-world impact.

By adding Clinical Guidelines as an attention source, Altmetric will enable users to:

  • See the practical applications of medical research Discover how a piece of research has gone from conception to practical application with Clinical Guidelines data and assess its long-term impact on the field.
  • Inform funding decisions with real-world evidence of clinical practice See where funding has made a tangible real-world impact with Clinical Guidelines data.
  • Identify the right journals driving innovation in the medical field – Identify which journals contribute most to Clinical Guidelines, informing publication strategy. 

Altmetric users will be able to see attention from Clinical Guidelines from today.

Amye Kenall, Vice President of Product, Data & Analytics Hub, Digital Science, said: “Tracking research referenced in Clinical Guidelines is a major step forward in understanding the impact of that research and its translation into healthcare.

“This will be of particular interest to medical affairs professionals, research funding bodies, and to academic and clinical researchers and their institutions, helping them better understand the practical applications and long-term impact of their research.

“By adding Clinical Guidelines data to our data sources, we’re enabling users to see the highest form of clinical impact of medical and health research.”

Find out more about Clinical Guidelines in Altmetric

About Altmetric

Altmetric is a leading provider of alternative research metrics, helping everyone involved in research gauge the impact of their work. We serve diverse markets including universities, institutions, government, publishers, corporations, and those who fund research. Our powerful technology searches thousands of online sources, revealing where research is being shared and discussed. Teams can use our powerful Altmetric Explorer application to interrogate the data themselves, embed our dynamic ‘badges’ into their webpages, or get expert insights from Altmetric’s consultants. Altmetric is part of the Digital Science group, dedicated to making the research experience simpler and more productive by applying pioneering technology solutions. Find out more at altmetric.com and follow @altmetric on X.

About Digital Science

Digital Science is an AI-focused technology company providing innovative solutions to complex challenges faced by researchers, universities, funders, industry and publishers. We work in partnership to advance global research for the benefit of society. Through our brands – Altmetric, Dimensions, Figshare, IFI CLAIMS Patent Services, metaphacts, OntoChem, Overleaf, ReadCube, Scismic, Symplectic, and Writefull – we believe when we solve problems together, we drive progress for all. Visit www.digital-science.com and follow @digitalsci on X or on LinkedIn.

Media contact

David Ellis, Press, PR & Social Manager, Digital Science: Mobile +61 447 783 023, [email protected]


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

link

Leave a Reply

Your email address will not be published. Required fields are marked *